array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(659)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(120) "Venous Blood Collection Devices Market to Witness Outstanding Growth by 2030 | Sarstedt, Qiagen NV, Bio-Rad Laboratories"
["snippet_en"]=>
string(100) "The latest report titled ‘Venous Blood Collection Devices Market’ Global Industry Trends, Share,"
["url"]=>
string(174) "https://ekz-crosstour.ch/news/der-markt-fuer-venoese-blutentnahmegeraete-wird-bis-2030-ein-herausragendes-wachstum-verzeichnen-sarstedt-qiagen-nv-bio-rad-laboratories/484463/"
["image_url"]=>
NULL
["source"]=>
string(16) "ekz-crosstour.ch"
["publication_date"]=>
string(10) "2023-12-03"
["categories"]=>
array(2) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(15) "Market Movement"
}
}
[1]=>
array(7) {
["title_en"]=>
string(81) "Bio-Rad Launches First StarBrightTM Red Dye and Extends Range of Antibody Markers"
["snippet_en"]=>
string(206) "Bio-Rad Laboratories announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range. With 29 additional targets the range also includes dog, cow, and pig targets."
["url"]=>
string(143) "https://www.technologynetworks.com/analysis/product-news/bio-rad-launches-first-starbright-red-dye-and-extends-range-of-antibody-markers-378449"
["image_url"]=>
NULL
["source"]=>
string(22) "technologynetworks.com"
["publication_date"]=>
string(10) "2023-09-05"
["categories"]=>
array(2) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(14) "Product Launch"
}
}
[2]=>
array(7) {
["title_en"]=>
string(58) "Bio-Rad (BIO) Global Expansion Strong, FX Woe Dents Growth"
["snippet_en"]=>
string(195) "Bio-Rad BIO is currently focused on international expansion. Yet, unfavorable macroeconomic conditions continue to weigh heavily on its stocks. The stock currently carries a Zacks Rank #3 (Hold)."
["url"]=>
string(87) "https://www.nasdaq.com/articles/bio-rad-bio-global-expansion-strong-fx-woe-dents-growth"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-03-09"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[3]=>
array(7) {
["title_en"]=>
string(83) "Cytek Biosciences partners with Bio-Rad to expand reagent portfolios - BioVoiceNews"
["snippet_en"]=>
string(75) "New agreement enhances high-parameter panels on Cytek Cell Analysis Systems"
["url"]=>
string(98) "https://www.biovoicenews.com/cytek-biosciences-partners-with-bio-rad-to-expand-reagent-portfolios/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1ac2ee55-b02b-4e68-89a8-3bd1d064e4b3"
["source"]=>
string(16) "biovoicenews.com"
["publication_date"]=>
string(10) "2023-02-08"
["categories"]=>
array(2) {
[0]=>
string(13) "Collaboration"
[1]=>
string(18) "Expansion & Growth"
}
}
[4]=>
array(7) {
["title_en"]=>
string(71) "Cytek(R) Biosciences Partners with Bio-Rad to Expand Reagent Portfolios"
["snippet_en"]=>
string(103) "Catch up on the headlines, understand the news and make better decisions, free in your inbox every day."
["url"]=>
string(111) "https://www.wsj.com/articles/cytek-r-biosciences-partners-with-bio-rad-to-expand-reagent-portfolios-01675778731"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/96bf0463-4255-4148-a055-ca3196e2db27"
["source"]=>
string(7) "wsj.com"
["publication_date"]=>
string(10) "2023-02-07"
["categories"]=>
array(2) {
[0]=>
string(13) "Collaboration"
[1]=>
string(18) "Expansion & Growth"
}
}
[5]=>
array(7) {
["title_en"]=>
string(125) "Statins Enhance Migratory Capacity by Upregulation of the Telomere Repeat-Binding Factor TRF2 in Endothelial Progenitor Cells"
["snippet_en"]=>
string(201) "Background— Cultivation of endothelial progenitor cells (EPCs) leads to premature replicative senescence, limiting ex vivo expansion for potential clinical cell therapy. Recent studies have linked se"
["url"]=>
string(66) "https://www.ahajournals.org/doi/10.1161/01.CIR.0000142866.50300.EB"
["image_url"]=>
NULL
["source"]=>
string(15) "ahajournals.org"
["publication_date"]=>
string(10) "2022-06-21"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[6]=>
array(7) {
["title_en"]=>
string(56) "Bio-Rad Expands Partnership with a Major Diagnostics ..."
["snippet_en"]=>
string(248) "05-03-2021· Bio-Rad Laboratories, Inc.( NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products entered a global partnership with Roche to provide their customers access to Bio-Rad 's complete line of InteliQ"
["url"]=>
string(192) "https://www.bio-rad.com/zh-cn/clinical-diagnostics/news/bio-rad-expands-partnership-with-major-diagnostics-company-provide-inteliq-portfolio-quality-controls?ID=Bio-Rad-Expands-Part_1614909697"
["image_url"]=>
NULL
["source"]=>
string(11) "bio-rad.com"
["publication_date"]=>
string(10) "2021-05-03"
["categories"]=>
array(2) {
[0]=>
string(13) "Collaboration"
[1]=>
string(18) "Expansion & Growth"
}
}
[7]=>
array(7) {
["title_en"]=>
string(58) "Bio-Rad Expands Joint Marketing Agreement with Siemens ..."
["snippet_en"]=>
string(246) "22-12-2020 · Bio-Rad has announced the expansion of its joint marketing agreement with Siemens Healthineers. The agreement establishes Bio-Rad’ s preferred supplier status with Siemens Healthineers, providing efficiencies in workflow and data"
["url"]=>
string(222) "https://www.bio-rad.com/ja-jp/clinical-diagnostics/news/bio-rad-expands-joint-marketing-agreement-with-siemens-healthineers-providing-quality-controls-optimize-efficiency-data-reliability?ID=Bio-Rad-Expands-Join_1608657778"
["image_url"]=>
NULL
["source"]=>
string(11) "bio-rad.com"
["publication_date"]=>
string(10) "2020-12-22"
["categories"]=>
array(2) {
[0]=>
string(13) "Collaboration"
[1]=>
string(18) "Expansion & Growth"
}
}
[8]=>
array(7) {
["title_en"]=>
string(38) "Bio-Rad Joins EMBL Partnership Program"
["snippet_en"]=>
string(85) "Will work to expand EMBL’s portfolio of scientific training courses for scientists."
["url"]=>
string(109) "https://www.contractpharma.com/contents/view_breaking-news/2019-10-24/bio-rad-joins-embl-partnership-program/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1205eda1-dc7f-4dae-aad1-ff7d00aa5146"
["source"]=>
string(18) "contractpharma.com"
["publication_date"]=>
string(10) "2019-10-24"
["categories"]=>
array(2) {
[0]=>
string(13) "Collaboration"
[1]=>
string(18) "Expansion & Growth"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
659 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Bio-Rad Laboratories announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range. With 29 additional targets the range also includes dog, cow, and pig targets.
Bio-Rad BIO is currently focused on international expansion. Yet, unfavorable macroeconomic conditions continue to weigh heavily on its stocks. The stock currently carries a Zacks Rank #3 (Hold).
Background— Cultivation of endothelial progenitor cells (EPCs) leads to premature replicative senescence, limiting ex vivo expansion for potential clinical cell therapy. Recent studies have linked se
05-03-2021· Bio-Rad Laboratories, Inc.( NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products entered a global partnership with Roche to provide their customers access to Bio-Rad 's complete line of InteliQ
22-12-2020 · Bio-Rad has announced the expansion of its joint marketing agreement with Siemens Healthineers. The agreement establishes Bio-Rad’ s preferred supplier status with Siemens Healthineers, providing efficiencies in workflow and data
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
